Cargando…

A single, continuous metric to define tiered serum neutralization potency against HIV

HIV-1 Envelope (Env) variants are grouped into tiers by their neutralization-sensitivity phenotype. This helped to recognize that tier 1 neutralization responses can be elicited readily, but do not protect against new infections. Tier 3 viruses are the least sensitive to neutralization. Because most...

Descripción completa

Detalles Bibliográficos
Autores principales: Hraber, Peter, Korber, Bette, Wagh, Kshitij, Montefiori, David, Roederer, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788501/
https://www.ncbi.nlm.nih.gov/pubmed/29350181
http://dx.doi.org/10.7554/eLife.31805
_version_ 1783296090832896000
author Hraber, Peter
Korber, Bette
Wagh, Kshitij
Montefiori, David
Roederer, Mario
author_facet Hraber, Peter
Korber, Bette
Wagh, Kshitij
Montefiori, David
Roederer, Mario
author_sort Hraber, Peter
collection PubMed
description HIV-1 Envelope (Env) variants are grouped into tiers by their neutralization-sensitivity phenotype. This helped to recognize that tier 1 neutralization responses can be elicited readily, but do not protect against new infections. Tier 3 viruses are the least sensitive to neutralization. Because most circulating viruses are tier 2, vaccines that elicit neutralization responses against them are needed. While tier classification is widely used for viruses, a way to rate serum or antibody neutralization responses in comparable terms is needed. Logistic regression of neutralization outcomes summarizes serum or antibody potency on a continuous, tier-like scale. It also tests significance of the neutralization score, to indicate cases where serum response does not depend on virus tiers. The method can standardize results from different virus panels, and could lead to high-throughput assays, which evaluate a single serum dilution, rather than a dilution series, for more efficient use of limited resources to screen samples from vaccinees.
format Online
Article
Text
id pubmed-5788501
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-57885012018-01-31 A single, continuous metric to define tiered serum neutralization potency against HIV Hraber, Peter Korber, Bette Wagh, Kshitij Montefiori, David Roederer, Mario eLife Epidemiology and Global Health HIV-1 Envelope (Env) variants are grouped into tiers by their neutralization-sensitivity phenotype. This helped to recognize that tier 1 neutralization responses can be elicited readily, but do not protect against new infections. Tier 3 viruses are the least sensitive to neutralization. Because most circulating viruses are tier 2, vaccines that elicit neutralization responses against them are needed. While tier classification is widely used for viruses, a way to rate serum or antibody neutralization responses in comparable terms is needed. Logistic regression of neutralization outcomes summarizes serum or antibody potency on a continuous, tier-like scale. It also tests significance of the neutralization score, to indicate cases where serum response does not depend on virus tiers. The method can standardize results from different virus panels, and could lead to high-throughput assays, which evaluate a single serum dilution, rather than a dilution series, for more efficient use of limited resources to screen samples from vaccinees. eLife Sciences Publications, Ltd 2018-01-19 /pmc/articles/PMC5788501/ /pubmed/29350181 http://dx.doi.org/10.7554/eLife.31805 Text en http://creativecommons.org/publicdomain/zero/1.0/ http://creativecommons.org/publicdomain/zero/1.0/This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication (http://creativecommons.org/publicdomain/zero/1.0/) .
spellingShingle Epidemiology and Global Health
Hraber, Peter
Korber, Bette
Wagh, Kshitij
Montefiori, David
Roederer, Mario
A single, continuous metric to define tiered serum neutralization potency against HIV
title A single, continuous metric to define tiered serum neutralization potency against HIV
title_full A single, continuous metric to define tiered serum neutralization potency against HIV
title_fullStr A single, continuous metric to define tiered serum neutralization potency against HIV
title_full_unstemmed A single, continuous metric to define tiered serum neutralization potency against HIV
title_short A single, continuous metric to define tiered serum neutralization potency against HIV
title_sort single, continuous metric to define tiered serum neutralization potency against hiv
topic Epidemiology and Global Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788501/
https://www.ncbi.nlm.nih.gov/pubmed/29350181
http://dx.doi.org/10.7554/eLife.31805
work_keys_str_mv AT hraberpeter asinglecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv
AT korberbette asinglecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv
AT waghkshitij asinglecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv
AT montefioridavid asinglecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv
AT roederermario asinglecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv
AT hraberpeter singlecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv
AT korberbette singlecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv
AT waghkshitij singlecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv
AT montefioridavid singlecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv
AT roederermario singlecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv